These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8896922)

  • 1. Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer.
    Sodee DB; Conant R; Chalfant M; Miron S; Klein E; Bahnson R; Spirnak JP; Carlin B; Bellon EM; Rogers B
    Clin Nucl Med; 1996 Oct; 21(10):759-67. PubMed ID: 8896922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
    Raj GV; Partin AW; Polascik TJ
    Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
    Nagda SN; Mohideen N; Lo SS; Khan U; Dillehay G; Wagner R; Campbell S; Flanigan R
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):834-40. PubMed ID: 17293236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer.
    Petronis JD; Regan F; Lin K
    Clin Nucl Med; 1998 Oct; 23(10):672-7. PubMed ID: 9790041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
    Fang DX; Stock RG; Stone NN; Krynyckyi BR; Kim CK; Machac J
    Tech Urol; 2000 Jun; 6(2):146-50. PubMed ID: 10798816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
    Rosenthal SA; Haseman MK; Polascik TJ
    Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.
    Wilkinson S; Chodak G
    J Urol; 2004 Jul; 172(1):133-6. PubMed ID: 15201753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.
    Kahn D; Williams RD; Manyak MJ; Haseman MK; Seldin DW; Libertino JA; Maguire RT
    J Urol; 1998 Jun; 159(6):2041-6; discussion 2046-7. PubMed ID: 9598514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy.
    Murphy GP; Elgamal AA; Troychak MJ; Kenny GM
    Prostate; 2000 Mar; 42(4):315-7. PubMed ID: 10679761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy.
    Proaño JM; Sodee DB; Resnick MI; Einstein DB
    J Urol; 2006 May; 175(5):1668-72. PubMed ID: 16600726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capromab Pendetide imaging of prostate cancer.
    Haseman MK; Rosenthal SA; Polascik TJ
    Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.
    Thomas CT; Bradshaw PT; Pollock BH; Montie JE; Taylor JM; Thames HD; McLaughlin PW; DeBiose DA; Hussey DH; Wahl RL
    J Clin Oncol; 2003 May; 21(9):1715-21. PubMed ID: 12721246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
    Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD; Goodman MM
    Radiology; 2011 Jun; 259(3):852-61. PubMed ID: 21493787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
    Koontz BF; Mouraviev V; Johnson JL; Mayes J; Chen SH; Wong TZ; Anscher MS; Sun L; Moul J; Polascik TJ
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):358-61. PubMed ID: 18164863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indium-111 capromab pendetide in the management of recurrent prostate cancer.
    Manyak MJ
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):175-81. PubMed ID: 18279057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma.
    Ellis RJ; Kim E; Foor R
    Expert Rev Mol Diagn; 2004 Jul; 4(4):435-41. PubMed ID: 15225091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer and prostate bed SPECT imaging with ProstaScint: semiquantitative correlation with prostatic biopsy results.
    Sodee DB; Ellis RJ; Samuels MA; Spirnak JP; Poole WF; Riester C; Martanovic DM; Stonecipher R; Bellon EM
    Prostate; 1998 Nov; 37(3):140-8. PubMed ID: 9792131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers.
    Sodee DB; Malguria N; Faulhaber P; Resnick MI; Albert J; Bakale G
    Urology; 2000 Dec; 56(6):988-93. PubMed ID: 11113745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging.
    Wong WW; Schild SE; Vora SA; Ezzell GA; Nguyen BD; Ram PC; Roarke MC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e423-9. PubMed ID: 21477947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer.
    Anderson RS; Eifert B; Tartt S; King P
    Urology; 2000 Oct; 56(4):669. PubMed ID: 11018634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.